Search All UT System Experts

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Mauro Gacci, Karl Erik Andersson, Christopher Chapple, Mario Maggi, Vincenzo Mirone, Matthias Oelke, Hartmut Porst, Claus Roehrborn, Christian Stief, François Giuliano

Research output: Contribution to journal › Review article › peer-review

103 Scopus citations

Fingerprint

Dive into the research topics of 'Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences